LSIPR 50 2018: Jean-François Formela

29-08-2018

Jean-François Formela was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

jfformela_atlasventures.jpg

Name: Jean-François Formela

Organisation: Atlas Venture


Jean-François Formela, LSIPR 50, LSIPR 50 2018, Atlas Venture, IFM Therapeutics, Intellia Therapeutics, F-star, Kyn Therapeutics, Spero Therapeutics

LSIPR